Bellevue Group AG (BBN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bellevue Group AG (BBN) has a cash flow conversion efficiency ratio of 0.150x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF16.84 Million ≈ $21.29 Million USD) by net assets (CHF112.53 Million ≈ $142.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bellevue Group AG - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Bellevue Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BBN liabilities breakdown for a breakdown of total debt and financial obligations.
Bellevue Group AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bellevue Group AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nyxoah
BR:NYXH
|
-0.402x |
|
Woorim Machinery Co. Ltd
KQ:101170
|
-0.035x |
|
Easy Field
TWO:6425
|
-0.057x |
|
Business Online PCL
BK:BOL
|
0.012x |
|
Alpha Cognition Inc
NASDAQ:ACOG
|
-0.158x |
|
Aesler Grup Internasional Tbk Pt
JK:RONY
|
-1.290x |
|
HYUNDAI FEED Inc
KQ:016790
|
0.015x |
|
Kyung Nong Corporation
KO:002100
|
0.043x |
Annual Cash Flow Conversion Efficiency for Bellevue Group AG (2002–2024)
The table below shows the annual cash flow conversion efficiency of Bellevue Group AG from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see BBN stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CHF118.52 Million ≈ $149.84 Million |
CHF9.40 Million ≈ $11.89 Million |
0.079x | +9.33% |
| 2023-12-31 | CHF122.47 Million ≈ $154.83 Million |
CHF8.89 Million ≈ $11.23 Million |
0.073x | -65.51% |
| 2022-12-31 | CHF133.89 Million ≈ $169.27 Million |
CHF28.17 Million ≈ $35.61 Million |
0.210x | -55.77% |
| 2021-12-31 | CHF146.59 Million ≈ $185.33 Million |
CHF69.73 Million ≈ $88.16 Million |
0.476x | -46.92% |
| 2020-12-31 | CHF165.82 Million ≈ $209.64 Million |
CHF148.60 Million ≈ $187.87 Million |
0.896x | +343.58% |
| 2019-12-31 | CHF198.35 Million ≈ $250.77 Million |
CHF-72.98 Million ≈ $-92.27 Million |
-0.368x | -500.65% |
| 2018-12-31 | CHF442.17 Million ≈ $559.02 Million |
CHF40.61 Million ≈ $51.34 Million |
0.092x | +65.66% |
| 2017-12-31 | CHF425.01 Million ≈ $537.33 Million |
CHF23.56 Million ≈ $29.79 Million |
0.055x | -26.43% |
| 2016-12-31 | CHF440.36 Million ≈ $556.73 Million |
CHF33.18 Million ≈ $41.95 Million |
0.075x | +126.22% |
| 2015-12-31 | CHF135.96 Million ≈ $171.89 Million |
CHF-39.07 Million ≈ $-49.39 Million |
-0.287x | -928.69% |
| 2014-12-31 | CHF402.44 Million ≈ $508.80 Million |
CHF-11.24 Million ≈ $-14.21 Million |
-0.028x | +94.47% |
| 2013-12-31 | CHF149.45 Million ≈ $188.95 Million |
CHF-75.51 Million ≈ $-95.47 Million |
-0.505x | -176.98% |
| 2012-12-31 | CHF161.21 Million ≈ $203.82 Million |
CHF105.81 Million ≈ $133.77 Million |
0.656x | +1900.24% |
| 2011-12-31 | CHF190.63 Million ≈ $241.00 Million |
CHF6.25 Million ≈ $7.91 Million |
0.033x | +105.45% |
| 2010-12-31 | CHF294.84 Million ≈ $372.76 Million |
CHF-177.59 Million ≈ $-224.53 Million |
-0.602x | -440.16% |
| 2009-12-31 | CHF332.73 Million ≈ $420.66 Million |
CHF58.92 Million ≈ $74.49 Million |
0.177x | -61.43% |
| 2008-12-31 | CHF454.64 Million ≈ $574.79 Million |
CHF208.73 Million ≈ $263.89 Million |
0.459x | +8.52% |
| 2007-12-31 | CHF478.14 Million ≈ $604.50 Million |
CHF202.29 Million ≈ $255.75 Million |
0.423x | +275.92% |
| 2003-12-31 | CHF301.42 Million ≈ $381.08 Million |
CHF-72.49 Million ≈ $-91.65 Million |
-0.240x | -125.99% |
| 2002-12-31 | CHF267.98 Million ≈ $338.80 Million |
CHF248.01 Million ≈ $313.55 Million |
0.925x | -- |
About Bellevue Group AG
Bellevue Group AG provides asset management services in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid caps, and private equity strategies; and multi asset,… Read more